# Neuronetics, Inc.: filings

STIM · Nasdaq · CIK 1227636 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/stim.md) · [Financials](/companies/stim/financials.md) · [Filings](/companies/stim/filings.md) · [Insiders](/companies/stim/insiders.md)

## Reports and events: 193 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 286, 8-K 132, 144 59, 3 33, 10-Q 25, SC 13G/A 25, SC 13G 21, DEFA14A 18, 10-K 8, DEF 14A 8, CORRESP 7, D 6, SCHEDULE 13D/A 6, 424B5 5, 4/A 5, 8-K/A 5, EFFECT 5, S-8 5, UPLOAD 5, S-3 4, SCHEDULE 13G 4, SCHEDULE 13G/A 4, SC 13D/A 3, SD 3, 3/A 2, 8-A12B 2, DRS/A 2, DRSLTR 2, PRE 14A 2, S-1/A 2, SC 13D 2, 144/A 1, 424B4 1, 8-A12B/A 1, CERT 1, CT ORDER 1, DEFM14A 1, DRS 1, PREM14A 1, S-1 1, S-1MEF 1, S-3/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-24 | 20:03 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002299.md) | Ownership report, active investor, amended | 0000921895-26-002299 |
| 2026-08-17 | 16:10 ET | [8-K](/filings/0001193125-26-354051.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-354051 |
| 2026-08-11 | 16:26 ET | [10-Q](/filings/0001104659-26-094078.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094078 |
| 2026-08-11 | 08:05 ET | [8-K](/filings/0001193125-26-343474.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-343474 |
| 2026-08-04 | 08:00 ET | [SCHEDULE 13D/A](/filings/0001193805-26-001017.md) | Ownership report, active investor, amended | 0001193805-26-001017 |
| 2026-07-20 | 16:10 ET | [8-K](/filings/0001193125-26-308921.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-308921 |
| 2026-06-23 | 16:38 ET | [8-K](/filings/0001193125-26-279601.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-279601 |
| 2026-05-29 | 16:45 ET | [8-K](/filings/0001193125-26-248525.md) | 5.07 Shareholder vote results | 0001193125-26-248525 |
| 2026-05-27 | 10:33 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001483.md) | Ownership report, active investor, amended | 0000921895-26-001483 |
| 2026-05-22 | 07:30 ET | [8-K](/filings/0001193125-26-235481.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-235481 |
| 2026-05-05 | 09:10 ET | [10-Q](/filings/0001104659-26-055322.md) | Quarterly report, period 2026-03-31 | 0001104659-26-055322 |
| 2026-05-05 | 08:04 ET | [8-K](/filings/0001193125-26-205117.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-205117 |
| 2026-04-09 | 16:02 ET | [DEF 14A](/filings/0001140361-26-013997.md) | Proxy statement, period 2026-05-28 | 0001140361-26-013997 |
| 2026-04-08 | 09:17 ET | [SCHEDULE 13D/A](/filings/0000921895-26-000945.md) | Ownership report, active investor, amended | 0000921895-26-000945 |
| 2026-04-06 | 16:40 ET | [8-K](/filings/0001193125-26-143876.md) | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-143876 |
| 2026-03-31 | 16:05 ET | [SCHEDULE 13D](/filings/0000921895-26-000850.md) | Ownership report, active investor | 0000921895-26-000850 |
| 2026-03-17 | 08:00 ET | [10-K](/filings/0001104659-26-029004.md) | Annual report, period 2025-12-31 | 0001104659-26-029004 |
| 2026-03-17 | 07:55 ET | [8-K](/filings/0001193125-26-109403.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-109403 |
| 2026-03-04 | 17:33 ET | [SCHEDULE 13D/A](/filings/0001193125-26-091919.md) | Ownership report, active investor, amended | 0001193125-26-091919 |
| 2026-03-02 | 16:30 ET | [8-K](/filings/0001193125-26-085509.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-085509 |
| 2026-02-25 | 16:45 ET | [8-K](/filings/0001193125-26-071892.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-071892 |
| 2026-02-10 | 17:09 ET | [8-K](/filings/0001193125-26-044912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-044912 |
| 2026-01-22 | 07:30 ET | [8-K](/filings/0001193125-26-018674.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-018674 |
| 2026-01-06 | 17:00 ET | [8-K](/filings/0001193125-26-004728.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-004728 |
| 2025-11-04 | 07:31 ET | [10-Q](/filings/0001104659-25-105924.md) | Quarterly report, period 2025-09-30 | 0001104659-25-105924 |
| 2025-11-04 | 07:10 ET | [8-K](/filings/0001193125-25-263541.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-263541 |
| 2025-08-12 | 16:15 ET | [SCHEDULE 13D/A](/filings/0000950170-25-107330.md) | Ownership report, active investor, amended | 0000950170-25-107330 |
| 2025-08-05 | 07:31 ET | [10-Q](/filings/0001558370-25-010180.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010180 |
| 2025-08-05 | 07:10 ET | [8-K](/filings/0001193125-25-173033.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-173033 |
| 2025-07-15 | 07:30 ET | [8-K](/filings/0001193125-25-159026.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-159026 |
| 2025-05-28 | 07:11 ET | [8-K](/filings/0001193125-25-128678.md) | 5.07 Shareholder vote results | 0001193125-25-128678 |
| 2025-05-06 | 07:30 ET | [10-Q](/filings/0001558370-25-006384.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006384 |
| 2025-05-06 | 07:10 ET | [8-K](/filings/0001193125-25-113283.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-113283 |
| 2025-04-10 | 16:32 ET | [DEF 14A](/filings/0001140361-25-013279.md) | Proxy statement, period 2025-05-22 | 0001140361-25-013279 |
| 2025-03-27 | 16:36 ET | [10-K](/filings/0001558370-25-003833.md) | Annual report, period 2024-12-31 | 0001558370-25-003833 |
| 2025-03-27 | 16:35 ET | [8-K/A](/filings/0001558370-25-003832.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-003832 |
| 2025-03-04 | 07:00 ET | [8-K](/filings/0001193125-25-044817.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-044817 |
| 2025-03-04 | 19:08 ET | [8-K](/filings/0001193125-25-044451.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-044451 |
| 2025-02-10 | 18:12 ET | [8-K](/filings/0001193125-25-022833.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-022833 |
| 2025-02-06 | 16:21 ET | [8-K/A](/filings/0001193125-25-021800.md) | 9.01 Financial statements and exhibits | 0001193125-25-021800 |
| 2025-01-13 | 08:04 ET | [8-K](/filings/0001193125-25-005006.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005006 |
| 2024-12-17 | 21:15 ET | [SC 13D](/filings/0001193125-24-280667.md) | Ownership report, active investor | 0001193125-24-280667 |
| 2024-12-10 | 16:45 ET | [8-K](/filings/0001193125-24-274383.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-274383 |
| 2024-11-13 | 06:44 ET | [8-K/A](/filings/0001193125-24-256576.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-256576 |
| 2024-11-13 | 20:25 ET | [8-K](/filings/0001193125-24-256238.md) | 7.01 Regulation FD disclosure | 0001193125-24-256238 |
| 2024-11-12 | 07:31 ET | [10-Q](/filings/0001558370-24-015160.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015160 |
| 2024-11-12 | 07:03 ET | [8-K](/filings/0001193125-24-255114.md) | 5.07 Shareholder vote results | 0001193125-24-255114 |
| 2024-11-12 | 07:01 ET | [8-K](/filings/0001193125-24-255111.md) | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001193125-24-255111 |
| 2024-11-12 | 07:01 ET | [8-K](/filings/0001193125-24-255110.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255110 |
| 2024-11-01 | 17:18 ET | [8-K](/filings/0001193125-24-249941.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-249941 |

Page 1 of 4. [Older](/companies/stim/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.